Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

58.82
Delayed Data
As of Jul 22
 +0.03 / +0.05%
Today’s Change
45.69
Today|||52-Week Range
60.07
+11.36%
Year-to-Date
In Case You Missed It, 5 New Lung Cancer Drugs Have Been Approved Since October
Jul 23 / MotleyFool.com - Paid Partner Content
Technology Earnings Helping Market to Gain
Jul 20 / GuruFocus News - Paid Partner Content
T. Rowe Price Equity Income Fund Sells Apache, Johnson & Johnson in 2nd Quarter
Jul 21 / GuruFocus News - Paid Partner Content
5 Big Pharma Stocks Struggling to Raise Their Dividends
Jul 19 / MotleyFool.com - Paid Partner Content
Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly
Jul 21 / MotleyFool.com - Paid Partner Content
Celgene to partner Jounce in battle against cancerous cells
Jul 19 / FT.com - Paid Partner Content
Here's Why Myriad Genetics Is Down 26% in 2016
Jul 21 / MotleyFool.com - Paid Partner Content
Analyst: Merck's Fundamentals Don't Warrant Current Valuation
Jul 18 / TheStreet.com - Paid Partner Content
These 5 Healthcare Stocks Have Huge Dividend Yields -- Are Any Worth Buying?
Jul 21 / MotleyFool.com - Paid Partner Content
Merck (MRK) Stock Slides, BMO Downgrades
Jul 18 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close58.79
Today’s open58.99
Day’s range58.55 - 59.08
Volume6,269,481
Average volume (3 months)8,788,683
Market cap$162.8B
Dividend yield3.13%
Data as of 4:00pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+3.59%
Earnings growth (next 5 years)+5.05%
Revenue growth (last year)-7.92%
P/E ratio36.1
Price/Sales3.87
Price/Book3.66

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc+4.37+0.50%
NVSNovartis+0.77+0.93%
BMYBristol-Myers Squibb+0.18+0.24%
SNYSanofi+0.41+0.98%
Data as of 4:02pm ET, 07/22/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)$0.91
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Partner Offers

Search for Jobs